New Stanford SAINT protocol showing 90% remission rates — what it means for patients
Join the conversation
Sign in to commentDavid — that's the key question researchers are working on. The initial follow-up data shows durability comparable to standard TMS at 6 months, but we need more long-term studies. There's no evidence that accelerated delivery leads to faster relapse. In theory, the precise targeting might actually improve durability since you're stimulating exactly the right circuit.
Related Discussions
Explore TMS List
Treatments & Conditions
Insurance & Cost
-
Kaiser Permanente Coverage
-
Humana TMS Coverage
-
Medicare Coverage for TMS
- TMS Cost Guide
- TMS Cost Calculator
TMS Specialists
- Leslie Rokoske — Washington, DC
- Ralph Kuechle — Newport Beach, CA
- Tricia Ricketts-Facey — Danbury, CT
- Yuli Fradkin — Fort Lee, NJ